A Case of Hepatitis B Reactivation with Acute Flare Three Months After Tenofovir Prophylaxis Withdrawal in a Allogenic Hematopoietic Stem Cell Transplantation Patient

Hepatitis B virus (HBV) infection is a major health problem worldwide. HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and, prophylactic antiviral treatment is suggested to prevent this phenomenon. However, the duration of antiviral treatment in HSCT patients is not fully defined and the time of immune recovery is considered the best parameter for a drug to be safely interrupted. We aimed to present a case of hepatitis B reactivation after cessation of one-year prophylactic tenofovir treatment in a anti-hepatitis B core immunoglobulin G-positive patient who received allogenic HSCT treatment for chronic lymphocytic leukemia

Studies on the mitral valves and measurements of end-diastolic, end-systolic and heart minute volume, and myocardial contractibility indices of English racing and show-jumping horses using M-mode echocardiography

In this study, mitral valves, left ventricle volume and myocardial contractibility indices in English racing (n:30) and showjumping horses (n:30) were investigated using M-mode echocardiography